Nintedanib in idiopathic pulmonary fibrosis

被引：0
|
作者：
Venkatesan, Priya
机构：
来源：
LANCET RESPIRATORY MEDICINE | 2021年 / 9卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：E108 / E108
页数：1
相关论文
共 50 条
  • [21] Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
    Wollin, Lutz
    Wex, Eva
    Pautsch, Alexander
    Schnapp, Gisela
    Hostettler, Katrin E.
    Stowasser, Susanne
    Kolb, Martin
    EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (05) : 1434 - 1445
  • [22] Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis
    Hee-Young Yoon
    Sojung Park
    Dong Soon Kim
    Jin Woo Song
    Respiratory Research, 19
  • [23] Nintedanib in idiopathic pulmonary fibrosis: a guide to its use
    Keating G.M.
    Drugs & Therapy Perspectives, 2015, 31 (10) : 329 - 333
  • [24] Nintedanib delays Progress not only in idiopathic Pulmonary Fibrosis
    Krome, Susanne
    PNEUMOLOGIE, 2020, 74 (02): : 70 - 70
  • [25] Broad Therapeutic Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis
    Wells, Athol U.
    Rosas, Ivan O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193 (02) : 112 - 113
  • [26] Idiopathic Pulmonary Fibrosis Nintedanib slows the Progression of the Disease
    Weiss, Johannes
    PNEUMOLOGIE, 2016, 70 (07): : 434 - 434
  • [27] Nintedanib: A Novel Therapeutic Approach for Idiopathic Pulmonary Fibrosis
    Dimitroulis, Ioannis A.
    RESPIRATORY CARE, 2014, 59 (09) : 1450 - 1455
  • [28] Effect of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis Reply
    Costabel, Ulrich
    Stansen, Wibke
    Stowasser, Susanne
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (09) : 1275 - 1275
  • [29] Cost Analysis of Idiopathic Pulmonary Fibrosis: A Nintedanib Example
    Lebanova, Hristina
    Kirilov, Bogdan
    Grigorov, Evgeni
    Ninova, Vessela
    Getov, Ilko
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 142 - 143
  • [30] NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS: SAFETY AND TOLERABILITY
    Glaspole, I
    Lancaster, L.
    Hernandez, P.
    Inoue, Y.
    Wachtlin, D.
    Loaiza, L.
    Conoscenti, C.
    Quaresma, M.
    Stowasser, S.
    Richeldi, L.
    RESPIROLOGY, 2019, 24 : 34 - 34
12345